Mass drug administration of ivermectin and dihydroartemisinin-piperaquine against malaria in settings with high coverage of standard control interventions: A cluster-randomised controlled trial in The Gambia.
Journal article published in The Lancet Infectious Diseases and co-authored by PATH's Chris Drakeley and Hannah Slater.
Publication date: November 2022